Follow on our innovation
Carrier and linker technology for targeted delivery of RNAi
Bubendorf, Switzerland, Tuesday, January 24, 2023 – CIS Pharma engages additional resources in 2023 to develop a novel linker/carrier system to conjugate ASO and siRNA for targeted delivery. To widen the therapeutic use of [...]
CIS Pharma Christmas event in Basel
Basel, Switzerland, Thursday, December 15, 2022 – This year’s Christmas event takes the CIS Pharma team on a tour along traditional sites in the city of Basel. The journey starts at the northern district [...]
Patent application published covering novel technology to improve contact lens care solutions
Bubendorf, Switzerland, Saturday, June 5, 2021 - CIS Pharma’s new lens care patent application was published. The patent covers the latest developments in the field of contact lens care creating multi-purpose disinfecting solutions, MPDS, with [...]
Patent granted in USA for CIS Pharma novel contact lens coating technology
Bubendorf, Switzerland, Wednesday, May 26, 2021 - CIS Pharma has developed a coating technology to improve the comfort of silicone hydrogel contact lenses. The technology is based upon a block-copolymer technology comprising a hydrophilic [...]